Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 3 N=92 Effects of Stress-reducing Aromatherapy

Stress-related Problems
Primary: Percent of Baseline Level of Salivary Cortisol — 170.8; 224.7; 274.7; 106.4 percentage of baseline cortisol level — p=.005
Oregon Health and Science University Results Aug 2019 0.0% serious AE View details

Phase 2 N=92 Use of Aromatherapy to Reduce Symptom Burden

Anxiety · Chemotherapy-induced Nausea and Vomiting
Primary: Chemotherapy-induced Nausea, Vomiting, and Retching (CINVR) Symptoms at Baseline, 25 Hours, and 48 Hours — 9.6; 8.5; 5.2; 4.9 score on a scale — p=0.462
Indiana University Results May 2024 2.2% serious AE View details